As Sales Grow Hotter, Cresco Labs Sees the Sunny Side of Investing in Florida

Cresco Labs (CSE:CL) (OTCQX:CRLBF), ranked #5 on the Global Cannabis 50 of leading cannabis operators, announced this week its nationwide retail footprint hit 60 operating Sunnyside dispensaries through the opening of stores in West Palm Beach and Winter Park, Florida. The new stores expand Cresco Lab’s retail footprint to 25 dispensaries in the Sunshine State, where it has kept close in step with the dizzying growth of Florida’s medical market.  Cresco Labs is currently the No. 1 U.S. wholesaler of branded products.

“Having achieved 60 nationwide dispensaries, we’re proud of the progress we’ve made to date investing in our strategic retail footprint to normalize shopping for cannabis and broaden accessibility to high quality products in our brand portfolio,” says Charles Bachtell, CEO & Co-Founder of Cresco Labs, which last week marked a 9.8% increase in its stock price. “With more than 22 million state residents and the number of active patients increasing 71 percent over the past two years, Florida is undoubtedly one of the hottest medical cannabis markets in the country that we’ll continue to go deep in.”

Sunnyside West Palm Beach, located at 2710 Okeechobee Blvd., and Sunnyside Winter Park at 591 Semoran Blvd in Winter Park will offer a wide assortment of cannabis products from the company’s branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. Stores also have a curated selection of cannabis accessories. Store hours for both stores are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

Patients can place orders today, both in store and online, through the Sunnyside.shop website. For more information, visit www.Sunnyside.shop.